Acorda Therapeutics (ACOR) Soars: Stock Adds 10% in Session

Zacks

Acorda Therapeutics, Inc. (ACOR) was a big mover last session, as its shares rose over 10% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the healthcare company since Feb 3, as the stock is now up roughly 19%.

In the last 30-day frame, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggestive of more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can translate into more strength down the road.

Acorda currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Other better-ranked stocks in the medical sector include Gentium S.p.A (GENT), Emergent BioSolutions, Inc. (EBS) and Actelion Ltd. (ALIOF). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




ACORDA THERAPEUTICS INC (ACOR): Free Stock Analysis Report

GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report

EMERGENT BIOSOLUTIONS INC (EBS): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (0)